We are live on ! Find out more

49 hedge funds and large institutions have $3.55M invested in BioVie in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more capital invested

Capital invested by funds: $2.42M → $3.55M (+$1.12M)

23% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 13

0.07% more ownership

Funds ownership: 0.05%0.12% (+0.07%)

8% less funds holding

Funds holding: 5349 (-4)

30% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 10

80% less call options, than puts

Call options by funds: $47K | Put options by funds: $231K

Holders
49
Holders Change
-4
Holders Change %
-7.55%
% of All Funds
0.71%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
7
Increased
16
Reduced
13
Closed
10
Calls
$47K
Puts
$231K
Net Calls
-$184K
Net Calls Change
+$473K

BIVI Hedge Fund Activity: Q1 2024 in Review

49 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q1 2024, worth a combined $3.55M — up 46% from $2.42M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of BIVI and 7 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 16 added.

The largest buyer was Altium Capital Management, opening a new position worth an estimated $3.09M. The largest seller was Morgan Stanley, cutting an estimated $145K.

  • 49 institutional investors held BioVie (BIVI) as of Q1 2024, down from 53 in Q4 2023.
  • Funds reported $3.55M of BioVie stock for Q1 2024, up 46% quarter-over-quarter.
  • 7 funds opened new BioVie positions in Q1 2024 and 10 closed out, a net change of -3 holders.
  • The largest BioVie buyer in Q1 2024 was Altium Capital Management, an estimated $3.09M added.
  • The largest BioVie seller in Q1 2024 was Morgan Stanley, an estimated $145K sold.

Based on aggregated 13F filings for Q1 2024.